Dr. Rizwan Khan, D.O

NPI: 1407169477
Total Payments
$2,020
2023 Payments
$42.46
Companies
11
Transactions
32
Medicare Patients
3,496
Medicare Billing
$900,895

Payment Breakdown by Category

Other$1,328 (65.7%)
Food & Beverage$471.99 (23.4%)
Consulting$125.00 (6.2%)
Education$95.51 (4.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $1,328 1 65.7%
Food and Beverage $471.99 29 23.4%
Consulting Fee $125.00 1 6.2%
Education $95.51 1 4.7%

Top Paying Companies

Company Total Records Latest Year
Horizon Therapeutics plc $1,365 3 $0 (2023)
Shire North American Group Inc $233.41 8 $0 (2018)
Otsuka America Pharmaceutical, Inc. $130.75 3 $0 (2020)
OPKO Pharmaceuticals, LLC $63.52 4 $0 (2018)
Relypsa, Inc. $56.36 4 $0 (2018)
Amgen Inc. $51.72 3 $0 (2018)
Keryx Biopharmaceuticals, Inc. $39.42 2 $0 (2018)
Mallinckrodt LLC $23.51 2 $0 (2018)
Mallinckrodt Hospital Products Inc. $20.91 1 $0 (2023)
Fresenius USA Marketing, Inc. $18.81 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $42.46 2 Horizon Therapeutics plc ($21.55)
2020 $1,423 2 Horizon Therapeutics plc ($1,328)
2019 $34.35 2 Otsuka America Pharmaceutical, Inc. ($18.76)
2018 $233.42 15 OPKO Pharmaceuticals, LLC ($63.52)
2017 $286.76 11 Shire North American Group Inc ($172.12)

All Payment Transactions

32 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
08/01/2023 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $21.55 General
Category: KRYSTEXXA
07/10/2023 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $20.91 General
Category: IMMUNOLOGY
06/26/2020 Horizon Therapeutics plc KRYSTEXXA (Biological) Honoraria Cash or cash equivalent $1,327.50 General
Category: KRYSTEXXA
01/17/2020 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Education In-kind items and services $95.51 General
Category: NEPHROLOGY
12/13/2019 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $15.59 General
Category: KRYSTEXXA
04/05/2019 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug), JYNARQUE Food and Beverage In-kind items and services $18.76 General
Category: NEPHROLOGY
11/16/2018 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $15.20 General
Category: Hyperparathyroidism
10/19/2018 Shire North American Group Inc NATPARA (Drug) Food and Beverage In-kind items and services $13.40 General
Category: INTERNAL MEDICINE
10/05/2018 Amgen Inc. Parsabiv (Biological) Food and Beverage In-kind items and services $15.35 General
Category: Nephrology
09/21/2018 Keryx Biopharmaceuticals, Inc. Auryxia (Drug) Food and Beverage In-kind items and services $22.54 General
Category: Nephrology
09/07/2018 Shire North American Group Inc NATPARA (Drug) Food and Beverage In-kind items and services $16.99 General
Category: INTERNAL MEDICINE
08/10/2018 Otsuka America Pharmaceutical, Inc. SAMSCA (Drug), JYNARQUE Food and Beverage In-kind items and services $16.48 General
Category: NEPHROLOGY
06/29/2018 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $14.86 General
Category: Hyperparathyroidism
05/18/2018 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $13.06 General
Category: AUTOIMMUNE AND RARE DISEASE
05/18/2018 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $12.54 General
Category: Hyperkalemia
05/04/2018 Shire North American Group Inc NATPARA (Drug) Food and Beverage In-kind items and services $16.57 General
Category: INTERNAL MEDICINE
05/02/2018 Amgen Inc. Parsabiv (Biological) Food and Beverage In-kind items and services $18.03 General
Category: Nephrology
03/23/2018 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $16.13 General
Category: Hyperparathyroidism
03/08/2018 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $10.61 General
Category: Hyperkalemia
02/09/2018 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $17.33 General
Category: Hyperparathyroidism
01/19/2018 Shire North American Group Inc NATPARA (Drug) Food and Beverage In-kind items and services $14.33 General
Category: INTERNAL MEDICINE
12/01/2017 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $18.81 General
Category: Phosphate binder for ESRD
11/16/2017 Shire North American Group Inc NATPARA (Drug) Food and Beverage In-kind items and services $12.21 General
Category: INTERNAL MEDICINE
10/17/2017 Shire North American Group Inc NATPARA (Drug) Consulting Fee Cash or cash equivalent $125.00 General
Category: INTERNAL MEDICINE
10/06/2017 Shire North American Group Inc NATPARA (Drug) Food and Beverage In-kind items and services $16.77 General
Category: INTERNAL MEDICINE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 877 2,044 $323,666 $188,944
2022 8 710 1,676 $284,051 $182,765
2021 8 877 2,292 $373,759 $250,555
2020 9 1,032 2,582 $439,255 $278,630
Total Patients
3,496
Total Services
8,594
Medicare Billing
$900,895
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 82 297 $111,375 $81,390 73.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 154 657 $64,386 $40,251 62.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 200 351 $47,385 $24,022 50.7%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 53 84 $12,012 $7,911 65.9%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 48 48 $13,728 $6,227 45.4%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 19 23 $7,245 $5,283 72.9%
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes Office 2023 50 159 $12,720 $4,886 38.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 44 44 $8,140 $4,399 54.0%
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes Office 2023 51 93 $9,300 $3,486 37.5%
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 32 81 $8,100 $2,966 36.6%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 32 66 $9,900 $2,925 29.5%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2023 41 67 $13,400 $2,486 18.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 32 35 $4,025 $2,147 53.4%
99453 Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment Office 2023 39 39 $1,950 $565.50 29.0%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 89 287 $107,279 $81,233 75.7%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 206 782 $75,844 $44,033 58.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 193 331 $44,594 $25,474 57.1%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 63 63 $17,931 $9,569 53.4%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 63 107 $15,100 $8,614 57.0%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 26 34 $10,630 $8,037 75.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 38 38 $9,229 $3,921 42.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 32 34 $3,445 $1,885 54.7%
90960 Dialysis services (4 or more physician visits per month), patient 20 years of age and older Office 2021 102 361 $127,275 $99,684 78.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 251 1,119 $109,662 $63,728 58.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 207 376 $49,410 $35,303 71.4%

About Dr. Rizwan Khan, D.O

Dr. Rizwan Khan, D.O is a Internal Medicine healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2010. The National Provider Identifier (NPI) number assigned to this provider is 1407169477.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rizwan Khan, D.O has received a total of $2,020 in payments from pharmaceutical and medical device companies, with $42.46 received in 2023. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Honoraria" ($1,328).

As a Medicare-enrolled provider, Khan has provided services to 3,496 Medicare beneficiaries, totaling 8,594 services with total Medicare billing of $900,895. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Nephrology
  • Location Clermont, FL
  • Active Since 07/20/2010
  • Last Updated 09/17/2014
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1407169477

Products in Payments

  • KRYSTEXXA (Biological) $1,365
  • NATPARA (Drug) $233.41
  • JYNARQUE (Drug) $95.51
  • Rayaldee (Drug) $63.52
  • Veltassa (Drug) $56.36
  • ACTHAR (Biological) $44.42
  • Auryxia (Drug) $39.42
  • SAMSCA (Drug) $35.24
  • Parsabiv (Biological) $33.38
  • Velphoro (Drug) $18.81
  • Sensipar (Drug) $18.34
  • KRYSTEXXA (Drug) $16.95

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Clermont